Myocardial fibrosis as a matter of cell differentiation: opportunities for new antifibrotic strategies
Eur Heart J
.
2019 Mar 21;40(12):979-981.
doi: 10.1093/eurheartj/ehy307.
Authors
Carsten Tschöpe
1
2
3
,
Javier Díez
4
5
6
7
Affiliations
1
Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.
2
Department of Cardiology, Charité, University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
3
DZHK (German Center for Cardiovascular Research), Partner Site, Berlin, Germany.
4
Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamploma, Spain.
5
Departments of Nephrology and Cardiology and Cardiac Surgery, University of Navarra Clinic, Pamploma, Spain.
6
Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamploma, Spain.
7
CIBERCV, Carlos III Institute of Health, Madrid, Spain.
PMID:
29868759
DOI:
10.1093/eurheartj/ehy307
No abstract available
Publication types
Comment
MeSH terms
Cardiomyopathies*
Cell Differentiation
Fibroblasts
Fibrosis
Humans
Myofibroblasts*